AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel

Author： Zaccara Gaetano Giovannelli Fabio Cincotta Massimo Iudice Alfonso

ISSN： 1473-7175

Source： Expert Review of Neurotherapeutics, Vol.13, Iss.6, 2013-06, pp. : 647-655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The discovery and development of perampanel for the treatment of epilepsy

By Hanada Takahisa

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

By Rektor Ivan

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 225-235

Informa Healthcare

Access to resources Recommend Favorite

BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy

By Faught Edward

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

AMPA Receptor Potentiators for the Treatment of CNS Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 181-194

Bentham Science Publishers

Access to resources Recommend Favorite

New AMPA antagonists in epilepsy

By Russo Emilio Gitto Rosaria Citraro Rita Chimirri Alba De Sarro Giovambattista

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1371-1389

Informa Healthcare

Access to resources Recommend Favorite